Study Details
Full Title
A PHASE 3, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATION WITH RESPIRATORY SYNCYTIAL VIRUS STABILIZED PREFUSION F SUBUNIT VACCINE (RSVpreF) IN IMMUNOCOMPROMISED ADULTS
Principal Investigator
Cameron
Wolfe
Protocol Number
PRO00120982
Phase
III
Enrollment Status
Open to Enrollment